Skip to main content
Log in

Adalimumab

Cryptococcosis (first report) in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Horcajada JP, Peña JL, Martinez-Taboada VM, Pina T, Belaustegui I, Cano ME, García-Palomo JD, Fariñas MC.Invasive cryptococcosis associated with treatment with adalimumab, a tumour necrosis factor alpha-antagonist agent. 17th European Congress of Clinical Microbiology and Infectious Diseases and the 25th International Congress of Chemotherapy: abstr. P982, 31 Mar 2007. Available from: URL: http://www.eccmid-icc.org - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab. React. Wkly. 1149, 6 (2007). https://doi.org/10.2165/00128415-200711490-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711490-00017

Keywords

Navigation